Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
BROOKLYN, June 19, 2025 (GLOBE NEWSWIRE) -- HealthRX, a digital health platform…
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc.…
Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management
New York, June 07, 2025 (GLOBE NEWSWIRE) -- Ro Weight Loss, a…
Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of 4.00
Press release Maxim Group initiates the coverage of the CROSSJECT share with…
Best Anti-Snoring Device 2025: AirSnore Mouthpiece & Drops Review for Sleep Apnea & Deprivation Relief
Glasgow, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction Consistent, uninterrupted sleep is…
remMD Launches Glow Guide: A Smart Mobility Accessory Designed to Support Safer, Smarter Movement for Aging Adults
New York, New York, April 29, 2025 (GLOBE NEWSWIRE) -- remMD announces…
![Norgine welcomes TGA registration in Australia of IFINWIL (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]](https://i3.wp.com/mma.prnewswire.com/media/597589/4648918/Norgine_Logo.jpg?p=thumbnail&w=420&resize=420,280&ssl=1 "Norgine welcomes TGA registration in Australia of IFINWIL (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]"){kind=logo}
Norgine welcomes TGA registration in Australia of IFINWIL (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
IFINWIL®: now TGA registered in AustraliaChildren diagnosed with neuroblastoma are on average just…
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1×1 Meetings on Thursday, April 24, 2025
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or…
Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF)
New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat,…